In a recent study, AA attenuated renal hypertension by a multimodal mechanism including ACE inhibition to inhibit the AngII-AT1R and NADPH oxidase-NF-κB pathway (Maneesai et al., 2017). The gene discussed is AGT; the disease is renal hypertension.